GZERO Daily: the newsletter for people who love global politics
Sign up for our free newsletter to keep up with what’s going on around the world - and why it matters.
GZERO Daily: the newsletter for people who love global politics
We have updated our Privacy Policy and Terms of Use for Eurasia Group and its affiliates, including GZERO Media, to clarify the types of data we collect, how we collect it, how we use data and with whom we share data. By using our website you consent to our Terms and Conditions and Privacy Policy, including the transfer of your personal data to the United States from your country of residence, and our use of cookies described in our Cookie Policy.
{{ subpage.title }}
Drugmakers halve their prices to gain access to China market
January 02, 2021
January 03, 2021 5:00 AM
WASHINGTON • Drugmakers from AstraZeneca and GlaxoSmithKline to BeiGene have agreed to cut prices on some of their newest drugs in China by an average of 51 per cent in order to be covered by the country's insurance fund.
WASHINGTON • Drugmakers from AstraZeneca and GlaxoSmithKline to BeiGene have agreed to cut prices on some of their newest drugs in China by an average of 51 per cent in order to be covered by the country's insurance fund.
Chinese maker of Covid-19 vaccine gets $669m shot in the arm
December 07, 2020
December 08, 2020 5:00 AM
BEIJING • One of China's biggest generic drug makers is investing around US$500 million (S$669 million) to fund research and work on a front runner coronavirus vaccine from Sinovac Biotech that could be weeks away from being administered across the world.
BEIJING • One of China's biggest generic drug makers is investing around US$500 million (S$669 million) to fund research and work on a front runner coronavirus vaccine from Sinovac Biotech that could be weeks away from being administered across the world.
Vaccine expectations must be managed: Dawn
November 12, 2020
November 12, 2020 12:00 PM
The paper says that relying on an American or Chinese vaccine is impractical, as it may be months before either becomes available in Pakistan.
The paper says that relying on an American or Chinese vaccine is impractical, as it may be months before either becomes available in Pakistan.
How a Chinese firm jumped to the front of the coronavirus vaccine race
July 02, 2020
July 02, 2020 4:28 PM
BEIJING (BLOOMBERG) - When a group of Chinese scientists gathered over barbecue and beer in a Toronto backyard a decade ago, talk drifted to their homeland's vaccines, which had long lagged the developed world on quality and safety. Four of them decided to act.They left top positions at global pharmaceutical companies in Canada to set up a biotechnology firm half a world away in Tianjin, China, hoping to produce vaccines on par with Western countries. Now, that company, CanSino Biologics, is vaulting into the global spotlight as connections on both sides of the Pacific make it one of the front-runners in the race for a coronavirus vaccine.
BEIJING (BLOOMBERG) - When a group of Chinese scientists gathered over barbecue and beer in a Toronto backyard a decade ago, talk drifted to their homeland's vaccines, which had long lagged the developed world on quality and safety. Four of them decided to act.They left top positions at global pharmaceutical companies in Canada to set up a biotechnology firm half a world away in Tianjin, China, hoping to produce vaccines on par with Western countries. Now, that company, CanSino Biologics, is vaulting into the global spotlight as connections on both sides of the Pacific make it one of the front-runners in the race for a coronavirus vaccine.
India working to reduce reliance on Chinese drugs as tensions rise
June 20, 2020
June 21, 2020 5:00 AM
With border tensions rising, India is trying to reduce its significant dependency on China for pharmaceutical raw materials. The Indian pharmaceutical industry is the third largest in the world by production and 14th by value. Its low-cost and quality generic drug formulations have helped millions with HIV and cancer around the world.
With border tensions rising, India is trying to reduce its significant dependency on China for pharmaceutical raw materials. The Indian pharmaceutical industry is the third largest in the world by production and 14th by value. Its low-cost and quality generic drug formulations have helped millions with HIV and cancer around the world.
Deadly 'super fungus' Candida auris fuels surge in Chinese drugmakers' shares
April 11, 2019
April 11, 2019 1:08 PM
HONG KONG (BLOOMBERG) - A deadly fungus that is spreading across the globe is sending Chinese pharma stocks surging.
HONG KONG (BLOOMBERG) - A deadly fungus that is spreading across the globe is sending Chinese pharma stocks surging.
GZEROMEDIA
Subscribe to GZERO's daily newsletter
Most Popular Videos
Biden steps aside
21 July
Latest
Harris makes her campaign debut
23 July